Impact of selective serotonin reuptake inhibitors on weight loss after vertical sleeve gastrectomy.

Background: Mental health disorders, such as depression, are prominent within the bariatric population, with antidepressants ranking among the most frequently prescribed medications.

Objectives: Our surgery aimed to investigate selective serotonin reuptake inhibitor (SSRI) effects on weight loss in patients undergoing vertical sleeve gastrectomy (VSG).

Setting: University affiliated Community Hospital, United States.